LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020

Rhea-AI Summary

LogicBio Therapeutics (Nasdaq: LOGC) announced that CEO Fred Chereau will present at the Chardan Virtual Genetic Medicines Conference on October 5, 2020, at 11 AM ET. The presentation will be available via live audio webcast on LogicBio's website, with a replay accessible one hour after the event for 30 days. LogicBio focuses on developing medicines for rare diseases in pediatric patients using its GeneRide™ technology platform, which enables site-specific integration of therapeutic transgenes without nucleases, aiming for lifelong expression.

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced CEO Fred Chereau will present at the Chardan Virtual Genetic Medicines Conference on Monday, October 5, 2020 at 11 AM, ET.

A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.

About LogicBio Therapeutics

LogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology platform. GeneRide enables the site-specific integration of a therapeutic transgene in a nuclease-free and promoterless approach by relying on the native process of homologous recombination to drive potential lifelong expression. Headquartered in Lexington, Mass., LogicBio is committed to developing medicines that will transform the lives of pediatric patients and their families. For more information, please visit www.logicbio.com

Contacts:

Investors:
Matthew Lane

Gilmartin Investor Relation

matt@gilmartinir.com

Media:
Stephanie Simon

Ten Bridge Communications

Stephanie@tenbridgecommunications.com

617-581-9333

FAQ

When will LogicBio Therapeutics hold its presentation at the Chardan Virtual Genetic Medicines Conference?

LogicBio Therapeutics will present on October 5, 2020, at 11 AM ET.

Where can I watch the LogicBio Therapeutics presentation?

The presentation can be watched live on LogicBio's website under the 'Events and Presentations' section.

What technology does LogicBio Therapeutics use for gene editing?

LogicBio uses GeneRide™, a proprietary technology platform that allows site-specific integration of therapeutic transgenes.

What is the focus of LogicBio Therapeutics?

LogicBio Therapeutics focuses on developing medicines to treat rare diseases in pediatric patients.

How long will the replay of the LogicBio presentation be available?

The replay of the presentation will be available for 30 days after the live event.